logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hal W. Hirte

western university (university of western ontario)
H指数:57
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Marizomib用于新诊断的胶质母细胞瘤患者: 一项随机3期试验

NEURO-ONCOLOGY
IF13.4
2024-03-192
OAAI
Roth, Patrick; Gorlia, Thierry; Reijneveld, Jaap C.; de Vos, Filip; Idbaih, Ahmed; Frenel, Jean-Sebastien; Le Rhun, Emilie; Sepulveda, Juan Manuel; Perry, James; Masucci, G. Laura; Freres, Pierre; Hirte, Hal; Seidel, Clemens; Walenkamp, Annemiek; Lukacova, Slavka; Meijnders, Paul; Blais, Andre; Ducray, Francois; Verschaeve, Vincent; Nicholas, Garth; Balana, Carmen; Bota, Daniela A.; Preusser, Matthias; Nuyens, Sarah; Dhermain, Frederic; van den Bent, Martin; O'Callaghan, Chris J.; Vanlancker, Maureen; Mason, Warren; Weller, Michael
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

晚期肿瘤患者口服MDM2拮抗剂idasanutlin的每日和每周方案的I期研究

INVESTIGATIONAL NEW DRUGS
IF2.7
2021-06-2824
OAAI
Italiano, Antoine; Miller, Wilson H., Jr.; Blay, Jean-Yves; Gietema, Jourik A.; Bang, Yung-Jue; Mileshkin, Linda R.; Hirte, Hal W.; Higgins, Brian; Blotner, Steven; Nichols, Gwen L.; Chen, Lin Chi; Petry, Claire; Yang, Qi Joy; Schmitt, Christophe; Jamois, Candice; Siu, Lillian L.
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

耐铂卵巢癌患者mirvetuximab soravtansine与化疗的III期随机试验: 前瞻性I的初步分析

ANNALS OF ONCOLOGY
IF65.4
2021-06-01148
OA
Moore, K. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Konecny, G. E.; Banerjee, S.; Murphy, C. G.; Tanyi, J. L.; Hirte, H.; Konner, J. A.; Lim, P. C.; Prasad-Hayes, M.; Monk, B. J.; Pautier, P.; Wang, J.; Berkenblit, A.; Vergote, I; Birrer, M. J.
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

西地尼布联合化疗治疗复发性铂类敏感性卵巢癌 (ICON6): 一项III期随机试验的总生存期结果

ESMO OPEN
IF8.3
2021-04-0120
OAAI
Ledermann, J. A.; Embleton-Thirsk, A. C.; Perren, T. J.; Jayson, G. C.; Rustin, G. J. S.; Kaye, S. B.; Hirte, H.; Oza, A.; Vaughan, M.; Friedlander, M.; Gonzalez-Martin, A.; Deane, E.; Popoola, B.; Farrelly, L.; Swart, A. M.; Kaplan, R. S.; Parmar, M. K. B.
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
CLINICAL CANCER RESEARCH
IF10.2
2020-06-0120
OAAI
Dhani, Neesha C.; Hirte, Hal W.; Wang, Lisa; Burnier, Julia V.; Jain, Angela; Butler, Marcus O.; Welch, Stephen; Fleming, Gini F.; Hurteau, Jean; Matsuo, Koji; Matei, Daniela; Jimenez, Waldo; Johnston, Carolyn; Cristea, Mihaela; Tonkin, Katia; Ghatage, Prafull; Lheureux, Stephanie; Mehta, Anjali; Quintos, Judy; Tan, Qian; Kamel-Reid, Suzanne; Ludkovski, Olga; Tsao, Ming-Sound; Wright, John J.; Oza, Amit M.
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
JOURNAL OF MEDICAL GENETICS
IF3.7
2018-07-2437
OAAI
McCuaig, Jeanna M.; Stockley, Tracy L.; Shaw, Patricia; Fung-Kee-Fung, Michael; Altman, Alon D.; Bentley, James; Bernardini, Marcus Q.; Cormier, Beatrice; Hirte, Hal; Kieser, Katharina; MacMillan, Andree; Meschino, Wendy S.; Panabaker, Karen; Perrier, Renee; Provencher, Diane; Schrader, Kasmintan A.; Serfas, Kimberly; Tomiak, Eva; Wong, Nora; Young, Sean S.; Gotlieb, Walter Henri; Hoskins, Paul; Kim, Raymond H.
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial

肿瘤治疗领域联合替莫唑胺维持治疗与单独替莫唑胺维持治疗对胶质母细胞瘤患者生存的影响一项随机临床试验

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2017-12-191.7K
OAAI
Stupp, Roger; Taillibert, Sophie; Kanner, Andrew; Read, William; Steinberg, David M.; Lhermitte, Benoit; Toms, Steven; Idbaih, Ahmed; Ahluwalia, Manmeet S.; Fink, Karen; Di Meco, Francesco; Lieberman, Frank; Zhu, Jay-Jiguang; Stragliotto, Giuseppe; Tran, David D.; Brem, Steven; Hottinger, Andreas F.; Kirson, Eilon D.; Lavy-Shahaf, Gitit; Weinberg, Uri; Kim, Chae-Yong; Paek, Sun-Ha; Nicholas, Garth; Burna, Jordi; Hirte, Hal; Weller, Michael; Palti, Yoram; Hegi, Monika; Ram, Zvi

研究方向

暂未获取到该数据
L
Lillian L. Siu
H 指数:101论文数:1,283被引数:4.0万
A
Amit M. Oza
H 指数:103论文数:1,211被引数:5.7万
S
Sébastien J. Hotte
H 指数:51论文数:463被引数:9,916
W
William R. Walsh
H 指数:68论文数:793被引数:1.6万
P
Philippe L. Bédard
H 指数:68论文数:1,007被引数:2.3万
E
Elizabeth A. Eisenhauer
H 指数:73论文数:273被引数:6.2万
G
Gregory R. Pond
H 指数:79论文数:973被引数:2.3万
S
S. Percy Ivy
H 指数:52论文数:336被引数:1.2万
S
Stephen Welch
H 指数:37论文数:227被引数:9,294
L
Laurie Elit
H 指数:40论文数:206被引数:7,119